- Home
- TBPH vs RSVR Comparison
TBPH vs RSVR Comparison
Compare TBPH & RSVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBPH | RSVR |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | 100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 669.1M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | TBPH | RSVR |
|---|---|---|
| Price | $16.34 | $10.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $18.40 | $11.50 |
| AVG Volume (30 Days) | ★ 282.6K | 50.3K |
| Earning Date | 05-04-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $8.46 | $10.95 |
| Revenue Next Year | N/A | $4.16 |
| P/E Ratio | ★ N/A | $77.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.10 | $6.97 |
| 52 Week High | $21.03 | $10.43 |
Technical Indicators
Market Signals| Indicator | TBPH | RSVR |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 57.54 |
| Support Level | $16.14 | $9.64 |
| Resistance Level | $17.21 | $10.27 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 29.31 | 62.68 |
Price Performance
Historical ComparisonAbout TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. It operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the Music Publishing segment.